The Lancet issued a retraction of an influential study of hydroxychloroquine use in COVID-19 patients. Hours later, NEJM retracted a second study from the same group. News Alerts …read more
Congenital syphilis cases have more than tripled as a result of multiple missed opportunities for prevention during pregnancy, researchers say. Medscape Medical News …read more
In a phase 3 trial, combining cytoreductive surgery with chemotherapy significantly prolonged progression-free and overall survival among select patients with recurrent ovarian cancer. Medscape Medical News …read more
A new study ‘suggests that select [per- and polyfluoroalkyl substances] PFAS serum concentrations are associated with earlier natural menopause, a risk factor for adverse health outcomes in later life.’ Medscape Medical News …read more
Wearing a mask at home, even when everyone feels fine, might reduce the spread of COVID-19, a study suggests. But some physicians wonder whether the costs outweigh the benefits. Medscape Medical News …read more
Additionally, side effects were more common among participants in the HCQ group than the placebo group. One expert says the results raise the question of whether some ongoing trials should stop. Medscape Medical News …read more
We’re trying to understand why men are more vulnerable to COVID-19 and how we can use that information to improve outcomes. Medscape Ob/Gyn …read more
Will everyone get coronavirus eventually? If so, is there a strategy to get us through this pandemic as quickly as possible without leading to excess deaths? Medscape …read more
Daily dairy intake does not bolster bone mineral density at the femoral neck or lumbar spine, nor does it reduce osteoporotic fracture risk in women going through menopause. Medscape Medical News …read more
The Food and Drug Administration approved a medication for the management of heavy menstrual bleeding associated with uterine fibroids in premenopausal women. FDA Approvals …read more